# First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism

> **NCT03927508** · PHASE1 · COMPLETED · sponsor: **Thrombolex, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** r-tPA
- **DEVICE:** The Bashir™ Endovascular Catheter

## Key facts

- **NCT ID:** NCT03927508
- **Lead sponsor:** Thrombolex, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-14
- **Primary completion:** 2019-12-19
- **Final completion:** 2020-01-23
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03927508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03927508, "First - In - Man Study to Assess the Safety and Feasibility of The Bashir™ Endovascular Catheter for the Treatment of Acute Pulmonary Embolism". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03927508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*